Medical Imaging News

January 31, 2007

CHI Introduces a New Program to its Sixth World Pharma Congress

Interested in learning more about human microdosing technology? Plan now for "Microdosing and Phase 0: To Predict Failure and Success," a session scheduled to be part of the sixth annual World Pharmaceutical Congress.

Presented by the Cambridge Healthtech Institute (CHI), the event is slated for June 12-13 at the Pennsylvania Convention Center in Philadelphia.

After the keynote presentation—Safety Limits & Modeling the Human Dose, given by Robert Ings, PhD, vice president of drug metabolism and PK at Roche Palo Alto—attendees will learn more about microdosing by reviewing case studies and reviewing practical regulatory insight.

Several sessions also are dedicated to the technology involved, including the use of PET as an in vivo imaging tool and applications of new technologies in assessing new drugs. Attendees also can take part in three short courses covering accelerator mass spectrometry, cell culture, and drug metabolism.

Those who register online before March 30 can save up to $350.

Read more Medical Imaging News from our archives